KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Current Taxes: 2018-2019

Historic Current Taxes for Amneal Pharmaceuticals (AMRX) over the last 2 years, with Dec 2019 value amounting to $8.7 million.

  • Amneal Pharmaceuticals' Current Taxes rose 653.15% to $8.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $8.7 million, marking a year-over-year increase of 653.15%. This contributed to the annual value of $8.7 million for FY2019, which is 653.15% up from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Current Taxes stood at $8.7 million for FY2019, which was up 653.15% from $1.2 million recorded in FY2018.
  • In the past 5 years, Amneal Pharmaceuticals' Current Taxes ranged from a high of $8.7 million in FY2019 and a low of $1.2 million during FY2018.
  • Over the past 2 years, Amneal Pharmaceuticals' median Current Taxes value was $4.9 million (recorded in 2018), while the average stood at $4.9 million.
  • Data for Amneal Pharmaceuticals' Current Taxes shows a peak YoY skyrocketed of 653.15% (in 2019) over the last 5 years.
  • Amneal Pharmaceuticals' Current Taxes (Yearly) stood at $1.2 million in 2018, then surged by 653.15% to $8.7 million in 2019.